BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,088 filers reported holding BAXTER INTL INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $198,928 | +10.1% | 4,623 | -0.3% | 0.02% | 0.0% |
Q4 2023 | $180,616 | -15.6% | 4,637 | -0.7% | 0.02% | -20.0% |
Q2 2023 | $214,119 | -15.1% | 4,670 | -5.1% | 0.02% | -24.2% |
Q4 2022 | $252,279 | -99.9% | 4,921 | -16.6% | 0.03% | -25.0% |
Q3 2022 | $319,000,000 | -16.3% | 5,898 | 0.0% | 0.04% | -10.2% |
Q2 2022 | $381,000,000 | -15.1% | 5,898 | +2.2% | 0.05% | 0.0% |
Q1 2022 | $449,000,000 | -7.6% | 5,773 | +2.3% | 0.05% | -2.0% |
Q4 2021 | $486,000,000 | +6.6% | 5,644 | 0.0% | 0.05% | -5.7% |
Q3 2021 | $456,000,000 | 0.0% | 5,644 | 0.0% | 0.05% | -1.9% |
Q2 2021 | $456,000,000 | -4.4% | 5,644 | 0.0% | 0.05% | -11.5% |
Q1 2021 | $477,000,000 | +104966.1% | 5,644 | 0.0% | 0.06% | -1.6% |
Q4 2020 | $454,000 | -0.2% | 5,644 | 0.0% | 0.06% | -10.1% |
Q3 2020 | $455,000 | -9.5% | 5,644 | -3.1% | 0.07% | -14.8% |
Q2 2020 | $503,000 | +6.1% | 5,826 | 0.0% | 0.08% | -12.0% |
Q1 2020 | $474,000 | -99.9% | 5,826 | +12.6% | 0.09% | +16.5% |
Q4 2019 | $434,000,000 | +95494.7% | 5,173 | 0.0% | 0.08% | -12.2% |
Q3 2019 | $454,000 | +6.8% | 5,173 | 0.0% | 0.09% | +4.7% |
Q2 2019 | $425,000 | +1.0% | 5,173 | 0.0% | 0.09% | -3.4% |
Q1 2019 | $421,000 | +26.8% | 5,173 | +3.0% | 0.09% | -9.2% |
Q4 2018 | $332,000 | – | 5,023 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |